Skip to content

xeo+ Family

by Cutera, Inc.

510(k) K233237

Active European Union and United States

CE MDR CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK233237 Date15 Dec 2023ClearedStatusActive
European UnionCE/MDD EUDAMED Number— Date—StatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
28 Sep 2023
FDA decision
15 Dec 2023 (Substantially Equivalent)
FDA review time
78 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K233237 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K233237 decided 15 Dec 2023 Active
  • EUDAMED Active· +1 more in the status table

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD, CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
GEX
Device class
Class II
Regulation
21 CFR Part 878.4810
Advisory committee
General, Plastic Surgery
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The xeo+ Family is a class of laser-based devices designed for non-ablative skin remodeling and tissue tightening. These devices utilize fractional laser technology to target collagen production in the skin, promoting rejuvenation and improvement of skin texture, tone, and elasticity without damaging the epidermis.

The xeo+ Family is supplied as a reusable medical device intended for use in clinical settings such as dermatology offices and cosmetic surgery clinics. Devices in this family are not single-use and require proper sterilization between procedures. Authorized for use in the United States under FDA 510K clearance (K233237) and compliant with MDD and MDR directives, these devices are categorized under product code GEX for general plastic surgery applications.

Similar devices

Other devices filed under FDA product code GEX (Powered Laser Surgical Instrument).

Other devices from Cutera, Inc.

  • truSculpt iD

    Class II
  • Titan V

    Class II
  • CoolView

    Class II
  • AviClear

    Class II

See all devices from Cutera, Inc. →